Originally Posted by
blissfool
Merry Blismas to you all
2015 was a very good year for Blis, but 2016 will be I believe even better perhaps the tipping point to years of improved health for many people and profitable sales growth. 31/03/16 will see our first year of profit, on the back of 100% growth in sales with europe and North America leading the way, I'm picking Blis breaks thru the $6 Million dollar sales barrier. I am also picking that the board was over cautiuos with their $350K provision to fix the "dodgy european batch" and that some of that money will flow back into the P&L.
The relationships they have developed with Bluestone Pharma, Stratum Nutrition and NZPR in China will continue to gain momentumn in sales and provide Blis with more store front opportunities. It will be interesting to see their sales growth forecasts for the next fininacal year.
One of the biggest frustrations with this sector is the never ending tests and trials that companies have to complete if the want to sell their product in different countries/markets. Surely the world health organisation could have one global standard this would save companies like Blis alot of time & expense getting their product to market. 2016 should see a couple of Trials that will hopefully get alot of publicity and in turn generate sales. The first one is the NZ based study done with several partners including "cure Kids" that centres around Rheumatic fever, but the big one is the Sinopham trial in China as this has a direct link to about 1200 outlets. I am expecting big things from these as Blis has alway Blitzed these sorts of tests.
One thing I would like to see Blis tidy up is their accuarcy as along term share holder I am dissappointed with the annual banana skins we slip on that cost us money, Like $30000 for commenting to the media, $350000 because of a dodgy batch going out. Every year there will be a calamity in your bussiness, this year Blis had a flood these sort of events always add some unforecasted cost to your P&L and are tough enough to deal with, without us creating our own costly disasters that impact on shareholders funds.
To Barry Richardson, thank you for your guidance, patience, dilligence and conviction over the last decade, you have moved a company from the potential category on to the path of achieving its first profit and bring a great product to many different markets that will benefit alot of people. All the best for the future.
To the incoming CEO, Merry Xmas, happy new year, no pressure but we are expecting big things in the next few years.